Integrating network pharmacology and experimental validation reveals PI3K/AKT as a critical pathway in pachymic acid-induced inhibition of hepatocellular carcinoma
By: Jun Liang, Hongyu Zhang, Shixin Pan, Tao Si, Minzhong Tang and Zheng Peng
References
- Y. Zhao, X. Peng, Z. Zhong, W. Pan, J. Zheng, X. Tian and X. Han, Epidemiological and demographic analysis of liver cancer attributable to modifiable risk factors from 1990 to 2021, Sci. Rep. 15 (2025) Article ID 19217 (24 pages); https://doi.org/10.1038/s41598-025-02031-w
- Y. H. Yen, S. H. Moi, Y. W. Liu, C. C. Yong, C. C. Wang, W. F. Li and C. Y. Lin, Antiviral therapy is associated with achievement of statistical cure of patients undergoing liver resection for hepato-cellular carcinoma: A retrospective study, Updates Surg. 78 (2026) 1597–1605; https://link.springer.com/article/10.1007/s13304-026-02532-x
- W. Zhang, X. Wu, X. Sun, J. Wen, X. He, M. Zhang, G. Wang and Z. Xu, Dynamic liver dysfunction predicts poor survival in patients with EGFR-mutant non-small cell lung cancer and liver meta-stases treated with EGFR tyrosine kinase inhibitors, BMC Cancer 26(1) (2026) Article ID 270 (14 pages); https://doi.org/10.1186/s12885-026-15616-z
- W. Zhang, Z. Long, X. He, X. Wu, J. Wen, D. Ye, J. Chen and G. Wang, Efficacy and safety of first--line EGFR-TKI combined with chemotherapy versus EGFR-TKI monotherapy in patients with EGFR-mutant non-small cell lung cancer and liver metastases: A propensity score-matched analysis, Cancer Treat. Res. Commun. 46 (2026) Article ID 101108 (8 pages); https://doi.org/10.1016/j.ctarc.2026.101108
- X. Lv, M. Ma, Z. Zhao, Y. Li, J. Kong, G. Shao, W. Tang and F. Xiong, Degradable Multifunctional Microspheres for Combined Thermotherapy-Embolization-Immune Activation Therapy of Hepatocellular Carcinoma, Adv. Healthc. Mater. 15(10) (2025) Article ID e04261; https://doi.org/10.1002/adhm.202504261
- M. Demir, M. T. Avci, A. Agackiran, S. Emir, A. Acar and T. Canbak, Microwave ablation for hepatocellular carcinoma: A single-center experience and outcomes, North Clin. Istanb. 12(6) (2025) 700–706; https://doi.org/10.14744/nci.2025.34101
- H. Yi, M. Song, X. Lu, J. Li, J. Liu and H. Fu, Therapeutics in hepatobronchial fistula caused by microwave ablation for the treatment of recurrent hepatic carcinoma: A case report, J. Int. Med. Res. 54(1) (2026) 1–13; https://doi.org/10.1177/03000605251409678
- W. Y. Lee, K. I. Park, S. B. Bak, S. Lee, S. J. Bae, M. J. Kim, S. D. Park, C. O. Kim, J. H. Kim, Y. W. Kim and C. E. Kim, Evaluating current status of network pharmacology for herbal medicine focusing on identifying mechanisms and therapeutic effects, J. Adv. Res. 76 (2025) 799–815; https://doi.org/10.1016/j.jare.2024.12.040
- Y. Wang and L. Ma, Pachymic acid suppresses endometrial cancer cell migration by inhibiting the NR3C1/TGF-beta/Smad signaling pathway, Chem. Biol. Drug Des. 106(6) (2025) Article ID e70226; https://doi.org/10.1111/cbdd.70226
- M. Liu, L. Zheng, Y. Zhang and J. Tian, Mechanistic insights into pachymic acid’s action on triple-negative breast cancer through TOP2A targeting, Sci. Rep. 15(1) (2025) Article ID 2856 (12 pages); https://doi.org/10.1038/s41598-025-87286-z
- S. Cheng, K. Swanson, I. Eliaz, J. N. McClintick, G. E. Sandusky and D. Sliva, Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress, PLoS One 10(4) (2015) e0122270 (20 pages); https://doi.org/10.1371/journal.pone.0122270
- S. Cheng, I. Eliaz, J. Lin, A. Thyagarajan-Sahu and D. Sliva, Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7, Int. J. Oncol. 42(6) (2013) 1869–1874; https://doi.org/10.3892/ijo.2013.1902
- A. H. Gao, L. Zhang, X. Chen, Y. Chen, Z. Z. Xu, Y. N. Liu and H. Zhang, Inhibition of ovarian cancer proliferation and invasion by pachymic acid, Int. J. Clin. Exp. Pathol. 8(2) (2015) 2235–2241.
- H. Ling, X. Jia, Y. Zhang, L. A. Gapter, Y. S. Lim, R. Agarwal and K. Y. Ng, Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells, Mol. Carcinog. 49(3) (2010) 271–282; https://doi.org/10.1002/mc.20597
- J. Nie, H. Zhang, X. Li, J. Qin, J. Zhou, Y. Lu, N. Yang, Y. Li, H. Li and C. Li, Pachymic acid promotes ferroptosis and inhibits gastric cancer progression by suppressing the PDGFRB-mediated PI3K/Akt pathway, Heliyon 10(20) (2024) Article ID e38800 (13 pages); https://doi.org/10.1016/j.heliyon.2024.e38800
- F. Jiang, T. Zhu, C. Yang, Y. Chen, Z. Fu, L. Jiang and Y. Liu, Pachymic acid inhibits growth and metastatic potential in liver cancer HepG2 and Huh7 cells, Biol. Pharm. Bull. 46(1) (2023) 35–41; https://doi.org/10.1248/bpb.b22-00440
- D. Tang, M. Chen, X. Huang, G. Zhang, L. Zeng, G. Zhang, S. Wu and Y. Wang, SRplot: A free online platform for data visualization and graphing, PLoS One 18(11) (2023) e0294236 (8 pages); https://doi.org/10.1371/journal.pone.0294236
- T. Yang, S. Tian, Y. Wang, J. Ji and J. Zhao, Antitumor activity of pachymic acid in cervical cancer through inducing endoplasmic reticulum stress, mitochondrial dysfunction, and activating the AMPK pathway, Environ Toxicol. 37(9) (2022) 2121–2132; https://doi.org/10.1002/tox.23555
- Y. Jiang, L. Fan, Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism, J. Ethnopharmacol. 257 (2020) Article ID 112851; https://doi.org/10.1016/j.jep.2020.112851
- J. Zhang, L. Liu, H. Li and B. Zhang, Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism, Pharm. Biol. 59(1) (2021) 1256–1259; https://doi.org/10.1080/13880209.2021.1942924
- C. Lu, D. Cai and J. Ma, Pachymic acid sensitizes gastric cancer cells to radiation therapy by up-regulating Bax through hypoxia, Am. J. Chin. Med. 46(4) (2018) 875–890; https://doi.org/10.1142/S0192415X18500465
- G. B. Zhang, Q. Y. Li, Q. L. Chen and S. B. Su, Network pharmacology: a new approach for chinese herbal medicine research, Evid. Based Complement. Alternat. Med. 2013 (2013) Article ID 621423 (9 pages); https://doi.org/10.1155/2013/621423
- X. Hu, H. Guo, G. Sun and X. Wang, Patterns and mechanisms of the “treating skin with skin” therapy under traditional Chinese medicine analogical thinking based on data mining and network pharmacology), Zhong Nan Da Xue Xue Bao Yi Xue Ban 50(11) (2025) 2003–2016; https://doi.org/10.11817/j.issn.1672-7347.2025.250250
- Z. Liu, J. Yuan, Q. Zeng, Z. Wu, J. Yang and T. Lv, Tumor-derived ITIH2 activates PI3K\AKT pathway via THBS1 ubiquitination and promotes tumor angiogenesis in hepatocellular carcinoma, Biochim. Biophys. Acta Mol. Basis Dis. 1872(4) (2026) Article ID 168175; https://doi.org/10.1016/j.bbadis.2026.168175
- D. Gao, Z. Zhou, L. Chen, J. Zheng and J. Yang, CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H/Wnt/beta-Catenin signaling axis, BMC Cancer 25 (2025) Article ID 435 (9 pages); https://doi.org/10.1186/s12885-025-13808-7
- J. Zhou, S. Liu, Y. Song, J. Liu, Z. Tan, J. Liu, X. Han, Y. Xing, X. Wang, C. Peng, B. Sun and Y. Leng, CGR11 promotes hepatocellular carcinoma progression by regulating autophagy through the PI3K/AKT pathway, Front. Cell Dev. Biol. 13 (2025) Article ID 1692480 (17 pages); https://doi.org/10.3389/fcell.2025.1692480
- H. Zhang, H. Huang, F. Miao and J. Nan, Sea buckthorn flavonoids attenuate oxidative stress in hepatocellular carcinoma via suppression of PI3K/Akt and JAK pathways, Am. J. Transl. Res. 17(12) (2025) 9830–9845; https://doi.org/10.62347/MBJK9072
Language: English
Accepted on: Oct 11, 2026
Published on: Oct 26, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Jun Liang, Hongyu Zhang, Shixin Pan, Tao Si, Minzhong Tang, Zheng Peng, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.